federal_register: 2011-33554

All Federal Register documents (rules, proposed rules, notices, presidential documents) from 1994 to present. Nearly 1M documents with full-text search.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

document_number title type abstract publication_date pub_year pub_month html_url pdf_url agency_names agency_ids excerpts
2011-33554 Revisions to Labeling Requirements for Blood and Blood Components, Including Source Plasma Rule The Food and Drug Administration (FDA) is revising the labeling requirements for blood and blood components intended for use in transfusion or for further manufacture by combining, simplifying, and updating specific regulations applicable to labeling and circulars of information. These requirements will facilitate the use of a labeling system using machine-readable information that would be acceptable as a replacement for the "ABC Codabar" system for the labeling of blood and blood components. FDA is taking this action as a part of its efforts to comprehensively review and, as necessary, revise its regulations, policies, guidances, and procedures related to the regulation of blood and blood components. This final rule is intended to help ensure the continued safety of the blood supply and facilitate consistency in labeling. 2012-01-03 2012 1 https://www.federalregister.gov/documents/2012/01/03/2011-33554/revisions-to-labeling-requirements-for-blood-and-blood-components-including-source-plasma https://www.govinfo.gov/content/pkg/FR-2012-01-03/pdf/2011-33554.pdf Health and Human Services Department; Food and Drug Administration 221,199 The Food and Drug Administration (FDA) is revising the labeling requirements for blood and blood components intended for use in transfusion or for further manufacture by combining, simplifying, and updating specific regulations applicable to labeling...

Links from other tables